Anas Najjar

613 total citations
11 papers, 452 citations indexed

About

Anas Najjar is a scholar working on Oncology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Anas Najjar has authored 11 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Infectious Diseases and 3 papers in Molecular Biology. Recurrent topics in Anas Najjar's work include HIV/AIDS drug development and treatment (3 papers), Click Chemistry and Applications (2 papers) and Nanoparticle-Based Drug Delivery (2 papers). Anas Najjar is often cited by papers focused on HIV/AIDS drug development and treatment (3 papers), Click Chemistry and Applications (2 papers) and Nanoparticle-Based Drug Delivery (2 papers). Anas Najjar collaborates with scholars based in Palestinian Territory, United States and Israel. Anas Najjar's co-authors include Rafik Karaman, Fatma Haddad, Ahmad Amro, Vincent J. Picozzi, Margaret T. Mandelson and Jens Kort and has published in prestigious journals such as The Lancet, PLoS ONE and Molecules.

In The Last Decade

Anas Najjar

10 papers receiving 441 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anas Najjar Palestinian Territory	8	146	78	63	62	53	11	452
Jianping Zhu China	16	213 1.5×	76 1.0×	66 1.0×	55 0.9×	24 0.5×	47	647
Xinbo Zhou China	16	174 1.2×	95 1.2×	22 0.3×	91 1.5×	65 1.2×	47	578
Beata Gruber Poland	12	151 1.0×	68 0.9×	43 0.7×	57 0.9×	72 1.4×	43	491
Guofei Li China	17	186 1.3×	24 0.3×	110 1.7×	84 1.4×	32 0.6×	46	627
Carmine Varricchio United Kingdom	14	156 1.1×	148 1.9×	27 0.4×	20 0.3×	92 1.7×	25	464
Tim Quach Australia	17	234 1.6×	203 2.6×	69 1.1×	128 2.1×	42 0.8×	29	757
Rajni Khan India	7	200 1.4×	31 0.4×	71 1.1×	43 0.7×	159 3.0×	12	574
Carola Foerster Germany	7	122 0.8×	50 0.6×	31 0.5×	39 0.6×	18 0.3×	8	344
Tae‐Sung Koo South Korea	17	235 1.6×	65 0.8×	27 0.4×	103 1.7×	14 0.3×	60	702
Herman Borghys Belgium	12	125 0.9×	49 0.6×	78 1.2×	41 0.7×	104 2.0×	25	537

Countries citing papers authored by Anas Najjar

Since Specialization

Citations

This map shows the geographic impact of Anas Najjar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anas Najjar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anas Najjar more than expected).

Fields of papers citing papers by Anas Najjar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anas Najjar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anas Najjar. The network helps show where Anas Najjar may publish in the future.

Co-authorship network of co-authors of Anas Najjar

This figure shows the co-authorship network connecting the top 25 collaborators of Anas Najjar. A scholar is included among the top collaborators of Anas Najjar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anas Najjar. Anas Najjar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Picozzi, Vincent J., et al.. (2025). Pancreatic enzyme replacement therapy in advanced adenocarcinoma of the pancreas improved overall survival: a retrospective, single institution study. The Oncologist. 30(4).

2.

Najjar, Anas, et al.. (2021). Prevalence of chronic diseases in older Palestinian adults and common pharmacological interventions: a cross-sectional study. The Lancet. 398. S40–S40. 4 indexed citations

3.

Najjar, Anas, et al.. (2021). Knowledge and attitude of Palestinian women to contraceptives: a cross-sectional study. The Lancet. 398. S45–S45. 1 indexed citations

4.

Najjar, Anas, et al.. (2020). Newly Developed Prodrugs and Prodrugs in Development; an Insight of the Recent Years. Molecules. 25(4). 884–884. 51 indexed citations

5.

Najjar, Anas & Rafik Karaman. (2019). Successes, failures, and future prospects of prodrugs and their clinical impact. Expert Opinion on Drug Discovery. 14(3). 199–220. 20 indexed citations

6.

Najjar, Anas, et al.. (2018). Strategies for Enhancing the Permeation of CNS-Active Drugs through the Blood-Brain Barrier: A Review. Molecules. 23(6). 1289–1289. 59 indexed citations

7.

Najjar, Anas & Rafik Karaman. (2018). The prodrug approach in the era of drug design. Expert Opinion on Drug Delivery. 16(1). 1–5. 71 indexed citations

8.

Najjar, Anas, et al.. (2017). Recent Approaches to Platinum(IV) Prodrugs: A Variety of Strategies for Enhanced Delivery and Efficacy. Current Pharmaceutical Design. 23(16). 2366–2376. 41 indexed citations

9.

Haddad, Fatma, et al.. (2017). Dopamine and Levodopa Prodrugs for the Treatment of Parkinson’s Disease. Molecules. 23(1). 40–40. 140 indexed citations

10.

Najjar, Anas, et al.. (2017). Advanced Prodrug Strategies in Nucleoside and Non-Nucleoside Antiviral Agents: A Review of the Recent Five Years. Molecules. 22(10). 1736–1736. 41 indexed citations

11.

Najjar, Anas, et al.. (2015). Knowledge and Adherence to Medications among Palestinian Geriatrics Living with Chronic Diseases in the West Bank and East Jerusalem. PLoS ONE. 10(6). e0129240–e0129240. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact